Identification of Lamprey Variable Lymphocyte Receptors That Target the Brain Vasculature

Investigators described an innovative screening platform for identification of new blood–brain barrier targeting molecules from a class of lamprey antigen recognition proteins known as variable lymphocyte receptors.